Lipoprotein-associated phospholipase A2 is especially predictive of coronary artery disease among patients with the metabolic syndrome

被引：0
|
作者：
Lavasani, Farangis
May, Heidi T.
Horne, Benjamin D.
Anderson, Jeffrey L.
Carlquist, John F.
Wolfert, Robert L.
Pearson, Robert R.
Lanman, Richard B.
Muhlestein, Joseph B.
机构：
[1] LDS Hosp, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339A / 339A
页数：1
相关论文
共 50 条
  • [21] Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death
    May, Heidi T.
    Horne, Benjamin D.
    Anderson, Jeffrey L.
    Wolfert, Robert L.
    Muhlestein, Joseph B.
    Renlund, Dale G.
    Clarke, Jessica L.
    Kolek, Matthew J.
    Bair, Tami L.
    Pearson, Robert R.
    Sudhir, Krishnankutty
    Carlquist, John F.
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 997 - 1003
  • [22] Lipoprotein-associated phospholipase A2 as independent predictor of atherosclerosis among patients with zero coronary artery calcium score
    Kaczmarska, E.
    Dzielinska, Z.
    Kepka, C.
    Janas, J.
    Kunicki, P.
    Kryczka, K.
    Pracon, R.
    Kruk, M.
    Pregowski, J.
    Demkow, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 811 - 811
  • [23] Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease
    Li, Jiayong
    Zhou, Zhe
    Niu, Xingyun
    Li, Huidan
    CLINICAL LABORATORY, 2020, 66 (05) : 709 - 715
  • [24] Lipoprotein-Associated Phospholipase A2 as a Risk of Coronary Disease in Statin User
    Chung, Hyemoon
    Kim, Myung-Hyun
    Lee, Byoung Kwon
    Kwon, Hyuek Moon
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 39S - 39S
  • [25] Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
    Maiolino, Giuseppe
    Pedon, Luigi
    Cesari, Maurizio
    Frigo, Anna Chiara
    Wolfert, Robert L.
    Barisa, Marlena
    Pagliani, Leopoldo
    Rossitto, Giacomo
    Seccia, Teresa Maria
    Zanchetta, Mario
    Rossi, Gian Paolo
    PLOS ONE, 2012, 7 (10):
  • [26] Association of Lipoprotein-Associated Phospholipase A2 with Coronary Artery Disease in African-Americans and Caucasians
    Anuurad, Erdembileg
    Ozturk, Zeynep
    Enkhmaa, Byambaa
    Pearson, Thomas A.
    Berglund, Lars
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05): : 2376 - 2383
  • [27] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 LEVELS ARE ASSOCIATED WITH ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Tsalamandris, Sotirios
    Mourouzis, Konstantinos
    Miliou, Antigoni
    Georgiopoulos, Georgios
    Antonopoulos, Alexis
    Kokkou, Eleni
    Mpiri, Christina
    Papamikroulis, George-Angelo
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2335 - 2335
  • [28] Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients
    Ling, Yang
    Tang, Shengxing
    Cao, Yuhan
    Fu, Cong
    DISEASE MARKERS, 2020, 2020
  • [29] Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease
    Konstantinos Mourouzis
    Gerasimos Siasos
    Evangelos Oikonomou
    Marina Zaromitidou
    Vicky Tsigkou
    Alexis Antonopoulos
    Evanthia Bletsa
    Panagiota Stampouloglou
    Konstantinos Vlasis
    Manolis Vavuranakis
    Dimitris Tousoulis
    Lipids in Health and Disease, 20
  • [30] The Prognostic Utility of Lipoprotein-Associated Phospholipase A2 Activity Versus Mass in Patients With Stable Coronary Artery Disease
    O'Donoghue, Michelle
    Morrow, David A.
    Sloan, Sarah
    Sabatine, Marc S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A341 - A341
12345